Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15338322rdf:typepubmed:Citationlld:pubmed
pubmed-article:15338322lifeskim:mentionsumls-concept:C0020094lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C0147139lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C0076560lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C1321301lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C0010853lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C1336626lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C1442734lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C0279477lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C1742737lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C1704619lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C1533179lld:lifeskim
pubmed-article:15338322lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:15338322pubmed:issue12lld:pubmed
pubmed-article:15338322pubmed:dateCreated2004-11-26lld:pubmed
pubmed-article:15338322pubmed:abstractTextHTLV-1 is the causative agent of HAM/TSP. This neurological disease affects the CNS producing damage of the motor tracts at the spinal cord. The HAM/TSP pathogenesis remains undefined. It could include direct and indirect actions of HTLV-1. We studied the effect of purified HTLV-1 and the PBMC of 22 Chilean patients co-cultivated with fetal neurons of mouse (CNh cells): 8 HAM/TSP, 8 HTLV-1 carriers, and 6 non-infected controls. The viral antigens and provirus in CNh cells was evaluated with monoclonal and polyclonal antibodies reacting with HTLV-1 by immunofluorescence assay and PCR at 0, 7 and 15 days of co-cultures, respectively. Viral antigens were detected in 0.1-0.5%, and 0-0.3% of the neurons incubated with lymphocytes of HAM/TSP patients and HTLV-1 carriers, respectively. Neurons incubated with cells of 7 HAM/TSP patients, and 3 HTLV-1 carriers showed the presence of nucleotide sequences of tax gene. These results would be showing that CNh cells would express viral antigens and provirus. The HTLV-1 or their proteins were capable in vitro to produce structural and growth changes in the cytoskeleton of CNh neurons. In this series, the purified HTLV-1 was more effective in the neural changes than PBMC of HAM/TSP or HTLV-1 carriers.lld:pubmed
pubmed-article:15338322pubmed:languageenglld:pubmed
pubmed-article:15338322pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15338322pubmed:citationSubsetIMlld:pubmed
pubmed-article:15338322pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15338322pubmed:statusMEDLINElld:pubmed
pubmed-article:15338322pubmed:monthDeclld:pubmed
pubmed-article:15338322pubmed:issn0304-8608lld:pubmed
pubmed-article:15338322pubmed:authorpubmed-author:RamirezEElld:pubmed
pubmed-article:15338322pubmed:authorpubmed-author:CartierLLlld:pubmed
pubmed-article:15338322pubmed:authorpubmed-author:FloresRRlld:pubmed
pubmed-article:15338322pubmed:issnTypePrintlld:pubmed
pubmed-article:15338322pubmed:volume149lld:pubmed
pubmed-article:15338322pubmed:ownerNLMlld:pubmed
pubmed-article:15338322pubmed:authorsCompleteYlld:pubmed
pubmed-article:15338322pubmed:pagination2307-17lld:pubmed
pubmed-article:15338322pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:meshHeadingpubmed-meshheading:15338322...lld:pubmed
pubmed-article:15338322pubmed:year2004lld:pubmed
pubmed-article:15338322pubmed:articleTitleIn vitro cytoskeleton changes of mouse neurons induced by purified HTLV-1, and PBMC from HAM/TSP patients and HTLV-1 carriers.lld:pubmed
pubmed-article:15338322pubmed:affiliationSection of Virology, Public Health Institute of Chile, Santiago, Chile. eramirez@ispch.cllld:pubmed
pubmed-article:15338322pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15338322pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed